Olanib 50 mg (Olaparib) is an oral PARP inhibitor used in certain BRCA-mutated cancers, including ovarian and breast cancer. It blocks DNA repair mechanisms in cancer cells. Common side effects include nausea, weakness, anemia, and loss of appetite. Medical supervision is essential. https://oncomedicure.com/product/olanib-50-mg-olaparib/